###begin article-title 0
###xml 67 72 <span type="species:ncbi:9606">human</span>
Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts
###end article-title 0
###begin p 1
These authors contributed equally to the manuscript.
###end p 1
###begin p 2
This document may be redistributed and reused, subject to .
###end p 2
###begin title 3
Abstract
###end title 3
###begin p 4
###xml 564 565 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 583 584 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 463 468 <span type="species:ncbi:9606">Human</span>
Cardiac myofibroblasts are pivotal to adaptive remodelling after myocardial infarction (MI). These normally quiescent cells invade and proliferate as a wound healing response, facilitated by activation of matrix metalloproteinases, particularly MMP-2. Following MI these reparative events occur under chronically hypoxic conditions yet the mechanisms by which hypoxia might modulate MMP-2 activation and cardiac myofibroblast invasion have not been investigated. Human cardiac myofibroblasts cultured in collagen-supplemented medium were exposed to normoxia (20% O2) or hypoxia (1% O2) for up to 48 h. Secreted levels of total and active MMP-2 were quantified using gelatin zymography, TIMP-2 and membrane-associated MT1-MMP were quantified with ELISA, whole cell MT1-MMP by immunoblotting and immunocytochemistry and MT1-MMP mRNA with real-time RT-PCR. Cellular invasion was assessed in modified Boyden chambers and migration by scratch wound assay.
###end p 4
###begin p 5
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 389 390 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 585 590 <span type="species:ncbi:9606">human</span>
In the human cardiac myofibroblast, MT1-MMP was central to MMP-2 activation and activated MMP-2 necessary for invasion, confirmed by gene silencing. MMP-2 activation was substantially attenuated by hypoxia (P < 0.001), paralleled by inhibition of myofibroblast invasion (P < 0.05). In contrast, migration was independent of either MT1-MMP or MMP-2. Reduced membrane expression of MT1-MMP (P < 0.05) was responsible for the hypoxic reduction of MMP-2 activation, with no change in either total MMP-2 or TIMP-2. In conclusion, hypoxia reduces MMP-2 activation and subsequent invasion of human cardiac myofibroblasts by reducing membrane expression of MT1-MMP and may delay healing after MI. Regulation of these MMPs remains an attractive target for therapeutic intervention.
###end p 5
###begin title 6
Keywords
###end title 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 220 225 220 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib3" ref-type="bibr">[2,3]</xref>
###xml 431 436 431 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib4 bib5" ref-type="bibr">[3&#8211;5]</xref>
###xml 789 794 789 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib7" ref-type="bibr">[6,7]</xref>
###xml 872 879 872 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Fibroblasts account for up to two-thirds of the total cell number in the normal human heart [1] and maintain the integrity of myocardial structure through controlled proliferation and extracellular matrix (ECM) turnover [2,3]. Adverse remodelling following myocardial infarction (MI) is characterised by myocyte death, hypertrophy of surviving myocytes, proliferation, migration and invasion of cardiac myofibroblasts and fibrosis [3-5]. An important part of this process is the transformation of normally quiescent cardiac fibroblasts into the proliferative and invasive myofibroblast phenotype that can alter the structure of the cardiac interstitium through increased expression and activation of matrix-degrading metalloproteinases (MMPs), particularly the gelatinases MMP-2 and MMP-9 [6,7]. Gelatinase activation is a prerequisite for both proliferation and invasion in vivo and is required to promote myocardial infarct healing and adaptive remodelling. However, in the long-term this can lead to adverse myocardial remodelling characterised by impaired contractile function and fibrosis.
###end p 8
###begin p 9
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">[9]</xref>
###xml 705 708 705 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">[10]</xref>
###xml 1065 1069 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">[11]</xref>
Unlike MMP-9, which is primarily regulated at the transcriptional level, MMP-2 is constitutively expressed by cardiac myofibroblasts and secreted in a latent form (proMMP-2). Activation of proMMP-2 takes place at the cell membrane and requires the participation of both membrane-type 1 matrix metalloproteinase (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) in cancer cells [8]. MT1-MMP is itself expressed in a latent form and processed intracellularly to its active species by furin, a proprotein convertase that cleaves precursor proteins to their biologically active state [9]. Generation of active MT1-MMP and its transfer to the cell membrane is a critical step in MMP-2 activation [8] and, together with TIMP-2, facilitates membrane binding of proMMP-2 to MT1-MMP. Although the main role of TIMP-2 is that of physiological inhibition of MMP-2 and MT1-MMP by post-translational regulation [10], it is also essential for cell membrane binding of proMMP-2. This binding in turn promotes activation of proMMP-2 which facilitates ECM degradation [11].
###end p 9
###begin p 10
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib13" ref-type="bibr">[12,13]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">[17]</xref>
###xml 899 906 899 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib18" ref-type="bibr">[17,18]</xref>
###xml 934 938 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">[19]</xref>
###xml 551 554 <span type="species:ncbi:10116">rat</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 867 872 <span type="species:ncbi:9606">human</span>
###xml 1425 1430 <span type="species:ncbi:9606">human</span>
Acute coronary events such as MI lead to profound myocardial injury and are inevitably associated with periods of inadequate oxygen supply (hypoxia) to the myocardium. Hypoxia itself is a major cue for tissue remodelling in the cardiovascular system, in part via MMP activation [12,13]. Indeed, distinct responses in different cell types in a variety of species have been shown to be induced as a result of hypoxic insult. Typically, hypoxia has been reported to increase cellular activation of MMP-2 as demonstrated in monkey endothelial cells [14], rat cardiac fibroblasts [15] and human HT-1080 fibrosarcoma cells [16]. Interestingly however, although chronic hypoxia increased MMP-2 secretion in human endothelial cells, a decrease in its activation was observed [17]. Similarly, an inhibitory effect of chronic hypoxia on MMP-2 activation has been documented in human endometrial stromal cells [17,18] and proximal tubular cells [19]. It is clear therefore, that hypoxia-induced effects on MMP-2 activation are both species and cell-type specific and, importantly, the underlying mechanisms are not consistent. Since any changes to the regulation of matrix deposition and degradation in the myocardium have the potential to create deleterious effects on myocardial function, the present study was designed to investigate specifically the influence of chronic hypoxia on collagen-induced MMP-2 activation and invasion of human cardiac myofibroblasts.
###end p 10
###begin title 11
Materials and methods
###end title 11
###begin title 12
Reagents
###end title 12
###begin p 13
###xml 86 90 <span type="species:ncbi:9913">calf</span>
All cell culture reagents were purchased from Invitrogen (Paisley, UK), except foetal calf serum (FCS) that was from Biosera (Ringmer, East Sussex, UK). Invasion and migration assay chambers and inserts were from BD Biosciences (Oxford, UK). Real-time PCR reagents were from Applied Biosystems ().
###end p 13
###begin title 14
Cell culture
###end title 14
###begin p 15
###xml 595 599 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">[20]</xref>
###xml 715 722 704 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21 bib22" ref-type="bibr">[21,22]</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 163 170 <span type="species:ncbi:9606">patient</span>
###xml 795 803 <span type="species:ncbi:9606">patients</span>
Biopsies of human atrial appendage were obtained from patients undergoing elective coronary artery bypass grafting (CABG). Ethical committee approval and informed patient consent were obtained and the investigation conformed to the principles outlined in the Declaration of Helsinki. Primary cultures of atrial cardiac myofibroblasts were harvested and cultured in full growth medium (Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FCS, 2 mM L-glutamine, 100 mug/ml penicillin G, 100 mug/ml streptomycin and 0.25 mug/ml amphotericin) essentially as we have described previously [20]. Cells were characterised as myofibroblasts by co-expression of alpha-smooth muscle actin (alpha-SMA) and vimentin [21,22]. Experiments were performed on early passage cells (2-5) from different patients.
###end p 15
###begin p 16
HT-1080 cells were cultured in fibroblast full growth medium (DMEM plus 10% FCS) and serially passaged by trypsinisation.
###end p 16
###begin title 17
Collagen supplemented myofibroblast culture
###end title 17
###begin p 18
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 365 366 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 391 392 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 399 400 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 407 408 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 473 480 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Cardiac myofibroblasts (3 x 105) were plated in full growth medium and incubated overnight. Medium was then exchanged for serum free medium (SFM) for 48 h. Serum-starved cells were transferred to fresh medium supplemented with 0.5% FCS and 50 mug/ml Type I collagen (Calbiochem) and transferred to humidified incubators at 37 degreesC for 24-48 h in normoxia (5% CO2 in air) or hypoxia (1% O2, 5% CO2, 94% N2). Type I collagen culture conditions were used to represent the in vivo environment of cardiac myofibroblasts. Samples of conditioned media (CM) were collected for zymography and/or immunoassay (ELISA).
###end p 18
###begin title 19
Gelatin zymography
###end title 19
###begin p 20
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23 bib24" ref-type="bibr">[23,24]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 303 308 <span type="species:ncbi:9606">human</span>
Gelatin zymography and subsequent densitometric analysis were performed on myofibroblast CM as we have described previously [23,24]. Optimised loading volumes were determined by serial dilution of CM to ensure that band intensity was proportional to MMP-2 zymographic activity. CM from HT-1080 cells (a human fibrosarcoma cell line that constitutively secretes MMP-2) [16] was included on each gel as a positive control.
###end p 20
###begin title 21
ELISA
###end title 21
###begin p 22
###xml 314 315 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 327 328 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
MMP-2 or TIMP-2 protein levels in CM were quantified by ELISA (R&D Systems, Abingdon, UK). Membrane-bound MT1-MMP was measured by ELISA (Amersham Biosciences, Amersham, UK) of membrane fractions prepared following 15 min exposure of cells to 2 ml extraction buffer (50 mM Tris-HCl, pH 7.6; 1.5 mM NaCl; 0.5 mM CaCl2; 1 muM ZnCl2; 0.01% Brij-35; 0.25% Triton X-100) at 4 degreesC.
###end p 22
###begin title 23
Real-time RT-PCR
###end title 23
###begin p 24
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">[25]</xref>
###xml 432 441 429 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;&#916;CT</sup>
###xml 202 207 <span type="species:ncbi:9606">human</span>
Myofibroblasts were cultured in collagen-supplemented medium in normoxia/hypoxia for 24-48 h. RNA extraction and reverse transcription were performed as we described previously [25]. Real-time PCR with human MT1-MMP (Hs00237119_m1) primers and Taqman probes was performed using the Applied Biosystems 7500 Real-Time PCR System. Data are expressed as a percentage of beta-actin mRNA levels (Hs99999903_m1 primers) using the formula 2- DeltaCT x 100.
###end p 24
###begin title 25
Whole cell MT1-MMP levels
###end title 25
###begin p 26
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">[26]</xref>
###xml 368 369 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 457 458 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
MT1-MMP levels within the whole cell were analysed by immunocytochemistry and immunoblotting. For fluorescence immunocytochemistry, cells were fixed in 4% paraformaldehyde and stained using a previously described protocol [26]. For immunoblotting, non-reduced cell lysates were prepared by scraping into extraction buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM CaCl2, 0.05% Brij-35), sonicating 6 x 10 s (4 degreesC) and centrifugation for 15 min (8000 xg, 4 degreesC) to pellet cellular debris. Lysates were subsequently electrophoresed on a 7.5% SDS-PAGE gel, transferred to PVDF membrane and visualised using MT1-MMP antibody (ab38971; AbCam, Cambridge, UK) and enhanced chemiluminescence.
###end p 26
###begin title 27
Inhibition of lysosomal degradation
###end title 27
###begin p 28
Cells were cultured in normoxia/hypoxia in 24-well plates in collagen-supplemented media with a range of concentrations of the lysosomal inhibitor bafilomycin-A1 (Sigma-Aldrich, Poole UK). Following 48 h incubation, CM was collected and MMP-2 activation analysed by gelatin zymography.
###end p 28
###begin title 29
Cardiac myofibroblast phenotype
###end title 29
###begin p 30
###xml 265 269 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">[22]</xref>
Cells cultured for 48 h in normoxia/hypoxia in 8-well chamber slides, were fixed and stained with antibodies to alpha-SMA and vimentin, firmly establishing their myofibroblast phenotype in these conditions without additional transformation, as previously described [22].
###end p 30
###begin title 31
Proliferation assays
###end title 31
###begin p 32
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">[22]</xref>
Proliferation assays were performed as we described previously [22]. Cardiac myofibroblasts were cultured in parallel in normoxia and hypoxia in medium containing 0.5% and 10% FCS. Cell numbers were monitored over a 7-day period.
###end p 32
###begin title 33
Invasion assays
###end title 33
###begin p 34
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">[24]</xref>
###xml 361 362 361 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">[24]</xref>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">[24]</xref>
###xml 401 407 <span type="species:ncbi:9913">bovine</span>
Invasion assays were performed essentially as we described previously [24] using a modified Boyden chamber technique with Matrigel basement membrane matrix coated membranes (BD Biosciences, Oxford, UK). Chemoattractant (2.5% FCS in DMEM) was loaded into the lower chamber and cardiac myofibroblasts were cast in Type I collagen gels in the upper chamber (1 x 105 cells) in SFM supplemented with 0.25% bovine serum albumin (BSA). After a 48-h incubation period in normoxic or hypoxic conditions, processing and evaluation were performed [24]. For gene silencing studies, transfected myofibroblasts were incubated for 24 h in media supplemented with 0.4% FCS prior to the assay. After 22 h, cell supernatants were collected from the upper chambers for analysis by gelatin zymography and invasion quantified by counting the invaded cells in ten random high power fields (x400) for each membrane [24].
###end p 34
###begin title 35
Wound scratch migration assays
###end title 35
###begin p 36
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr">[27]</xref>
Wound scratch migration assays were performed essentially as described previously [27] with minor modifications. A single linear wound was made with a 10 ml pipette tip in confluent cultures of 48 h serum-starved cardiac myofibroblasts, then washed gently with PBS to remove cellular debris. The cells were transferred to fresh DMEM supplemented with 0.5% FCS and 50 mug/ml Type I collagen, and incubated at 37 degreesC under normoxic and hypoxic conditions. After 48 h cells were photographed using phase contrast microscopy (x40 magnification). The number of cells migrating beyond a marker 500 mum from the wound edge was counted.
###end p 36
###begin title 37
Transfection of siRNA oligonucleotides
###end title 37
###begin p 38
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 368 375 368 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25 bib28" ref-type="bibr">[25,28]</xref>
Cardiac myofibroblasts (3 x 105) were incubated overnight in medium supplemented with 0.4% FCS, prior to transfection with siRNA targeting MMP-2 (5'-CGGACAAAGAGUUGGCAGU-3', 200 nM, Eurogentec) or MT1-MMP (5'-GGAAUGAGGAUCUGAAUGG-3', 50 nM, Ambion) using Lipofectamine 2000 (Invitrogen), or mock transfected (Lipofectamine without siRNA) as we have previously described [25,28]. Gelatin zymography and ELISA were performed to confirm efficient silencing of MMP-2 and MT1-MMP respectively.
###end p 38
###begin title 39
Statistical analysis
###end title 39
###begin p 40
###xml 47 48 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 192 193 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 296 297 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
All results are expressed as mean +/- SEM with n representing the number of experiments on cells from different patients. Differences between treatment groups were analysed using paired ratio t-tests or one-way repeated measures ANOVA with a Bonferroni post-hoc test (GraphPad Prism software, ). P < 0.05 was considered statistically significant.
###end p 40
###begin title 41
Results
###end title 41
###begin title 42
Type I collagen induces MMP-2 activation that is attenuated by chronic hypoxia
###end title 42
###begin p 43
###xml 189 195 189 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 497 498 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 608 615 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figs. 1</xref>
###xml 717 723 705 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1000 1004 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 1213 1220 1189 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figs. 1</xref>
###xml 1366 1372 1330 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 867 872 <span type="species:ncbi:9606">human</span>
###xml 1417 1422 <span type="species:ncbi:9606">human</span>
Myofibroblasts cultured in the presence of Type I soluble collagen under normoxic conditions showed significant activation of MMP-2 compared with cells cultured in the absence of collagen (Fig. 1A), as evidenced by the appearance of a lower molecular weight zymogen band (62 kDa) in addition to the 72 kDa proprotein. There were no differences in secreted levels of total MMP-2 between cells cultured in the absence or presence of collagen (data not shown). After exposure to chronic hypoxia (1% O2, 48 h) collagen-induced MMP-2 activation was significantly and consistently attenuated by approximately 50% (Figs. 1A, B). This was not the result of cell death in hypoxia, since cell numbers were similar over 7 days (Fig. 4F), confirming that differences in MMP-2 activation were not attributable to variations in cell number. We repeated these experiments using the human fibrosarcoma cell line HT-1080 in which hypoxic regulation of MMP-2 secretion and activation has previously been characterised [16]. In marked contrast to the myofibroblasts, but in agreement with this previous report, HT-1080 cells exhibited a significant increase in MMP-2 activation (approximately 200%) compared with normoxic controls (Figs. 1C, D). In further agreement with this same report, an intermediate band of MMP-2 activation (approximately 68 kDa) was observed in HT-1080 media (Fig. 1C). Thus, the effects of hypoxia observed in human cardiac myofibroblasts were markedly different from those seen in HT-1080 cells.
###end p 43
###begin title 44
Hypoxia attenuates MT1-MMP but does not affect TIMP-2 or MMP-2
###end title 44
###begin p 45
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
###xml 423 429 423 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 466 472 466 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 535 541 535 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 701 708 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib29" ref-type="bibr">[11,29]</xref>
###xml 873 879 873 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1160 1166 1160 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1347 1353 1335 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1493 1499 1469 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
Activation of MMP-2 at the cell membrane requires formation of a ternary complex of MT1-MMP, TIMP-2 and proMMP-2 [8]. We therefore investigated whether the observed reduction in MMP-2 activation in myofibroblasts cultured in hypoxia might be due to changes in total MMP-2, TIMP-2 and/or MT1-MMP expression. Densitometric analysis of gelatin zymograms demonstrated no change in total MMP-2 secretion in response to hypoxia (Fig. 1A), and this was confirmed by ELISA (Fig. 2A). Similarly, hypoxia had no effect on TIMP-2 protein levels (Fig. 2B). We next quantified levels of MT1-MMP mRNA and, because it is the active form of MT1-MMP that traffics to the plasma membrane to facilitate MMP-2 activation [11,29], we also measured MT1-MMP protein in cell membrane and whole cell fractions using ELISA and immunoblotting. Hypoxia did not alter steady-state MT1-MMP mRNA levels (Fig. 2C). Immunocytochemistry revealed a general diffuse staining within the cytoplasm, with a more concentrated localisation of MT1-MMP at the cell periphery in normoxia. This association with the membrane was not apparent when cells were cultured under chronically hypoxic conditions (Fig. 2D). In keeping with the immunofluorescence findings, measurement of MT1-MMP in cell membrane preparations using ELISA showed a approximately 40% reduction under hypoxic conditions (Fig. 2E). Measurement of total MT1-MMP in whole cell lysates (ELISA and immunoblotting) also indicated a approximately 40% decrease with hypoxia (Fig. 2F).
###end p 45
###begin title 46
Lysosomal degradation of MT1-MMP is not enhanced by hypoxia
###end title 46
###begin p 47
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">[30]</xref>
###xml 539 546 539 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figs. 3</xref>
###xml 723 730 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figs. 3</xref>
As hypoxia reduced MT1-MMP protein without affecting MT1-MMP mRNA, we looked for evidence of hypoxia-induced MT1-MMP degradation. MT1-MMP is degraded by lysosomes [30], therefore cells were cultured with increasing concentrations of the lysosomal inhibitor bafilomycin-A1 to determine whether the decrease in MMP-2 activation could be attributable to enhanced degradation of MT1-MMP. Zymographic analysis of CM from cells cultured in normoxia revealed that bafilomycin-A1 increased activation of MMP-2 in a concentration-dependent manner (Figs. 3A, B). However, irrespective of bafilomycin-A1 treatment, cells cultured under hypoxic conditions exhibited attenuation of MMP-2 activation compared with normoxic counterparts (Figs. 3A, B).
###end p 47
###begin title 48
Hypoxia inhibits cardiac myofibroblast invasion, but not migration
###end title 48
###begin p 49
###xml 254 261 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figs. 4</xref>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figs. 1</xref>
###xml 612 619 612 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figs. 4</xref>
###xml 792 798 788 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
Cellular invasion requires two distinct phases; degradation of ECM followed by cellular migration towards a chemotactic stimulus. A 48 h hypoxic period led to a significant inhibition of myofibroblast invasion of almost 50% compared with normoxic cells (Figs. 4A, B). This was associated with a corresponding decrease in MMP-2 activation in the supernatants from cells used in these experiments (Figs. 1A, B). However, in the wound scratch assay, despite also observing a consistent inhibition of MMP-2 activation, there was no difference in cellular migration between the normoxic and hypoxic treatment groups (Figs. 4C, D). Immunocytochemical analysis of normoxic and hypoxic cells for the markers alpha-SMA and vimentin confirmed that the cells had retained their myofibroblast phenotype (Fig. 4E). These results together strongly suggest that MMP-2 activation is a prerequisite for cardiac myofibroblast invasion, but not migration.
###end p 49
###begin title 50
MT1-MMP is required for collagen-stimulated MMP-2 activation and invasion, but not migration
###end title 50
###begin p 51
###xml 511 518 499 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figs. 5</xref>
###xml 633 639 609 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 763 769 739 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
Since we had demonstrated that hypoxia reduced invasion (but not migration), and also reduced both MT1-MMP protein levels together with MMP-2 activity, we sought to establish whether these effects were sufficient to inhibit myofibroblast invasion. Myofibroblasts transfected with siRNA targeting MT1-MMP or MMP-2 were cultured in collagen for 48 h and supernatants subjected to zymography. Total MMP-2 was selectively reduced by approximately 50% with MMP-2 gene silencing, but was unaffected by MT1-MMP siRNA (Figs. 5A, B). Cells transfected with MT1-MMP siRNA exhibited a approximately 50% decrease in membrane MT1-MMP expression (Fig. 5C). Importantly, selective silencing of either MT1-MMP or MMP-2 resulted in a significant reduction in active MMP-2 levels (Fig. 5D), to a level comparable with that observed in myofibroblasts during hypoxic culture.
###end p 51
###begin p 52
###xml 226 232 214 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 386 392 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 439 445 427 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
The functional roles of both MT1-MMP and MMP-2 were examined by studying siRNA-treated cells in invasion and migration assays. Silencing of either MT1-MMP or MMP-2 resulted in decreased cellular invasion of approximately 50% (Fig. 5E). Parallel wound scratch assays revealed no difference in myofibroblast migration between control and transfected groups, confirming that cell motility per se is independent of MT1-MMP and MMP-2 activity (Fig. 5F). These observations concur with our observed effects of hypoxia on cell function, thus confirming the pivotal role of membrane-associated MT1-MMP activity in the mechanism of MMP-2 activation and invasion in this cell type.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 300 308 300 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 498 505 498 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">[29]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr">[31]</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
This study reveals mechanisms unique to human cardiac myofibroblasts of potential clinical significance, underscoring the importance of selecting appropriate experimental models. Cardiac myofibroblasts reside in a fibrillar collagen matrix in vivo, and we demonstrate here that collagen-supplemented in vitro cultures provide an appropriate physiological stimulus for activation of MMP-2 in human cardiac myofibroblasts. Moreover, myofibroblasts in culture are phenotypically comparable with their in vivo counterparts [29] and similar studies have also been reported for other fibroblast cultures [31]. We show here that MMP-2 activation is a prerequisite for cellular invasion, a process fundamental to promotion of the early, adaptive healing response after myocardial injury and is attenuated by hypoxia.
###end p 54
###begin p 55
###xml 233 239 233 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib9 bib10" ref-type="bibr">[8&#8211;10]</xref>
###xml 437 447 437 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib15 bib16 bib17 bib32" ref-type="bibr">[14&#8211;17,32]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 459 462 <span type="species:ncbi:10116">rat</span>
###xml 562 567 <span type="species:ncbi:9606">human</span>
###xml 827 832 <span type="species:ncbi:9606">human</span>
Considerable evidence supports a role for MMP-2 and MT1-MMP in cellular invasion. ProMMP-2 displays a unique cell surface activation mechanism involving the formation of a trimolecular complex comprising MT1-MMP, TIMP-2 and proMMP-2 [8-10]. Therefore, MMP-2 activation can be regulated by changes in expression and/or activation of any of these molecules. In marked contrast to previously published studies using a variety of cell types [14-17,32], including rat cardiac fibroblasts [15], exposure to chronic hypoxia significantly attenuated MMP-2 activation in human cardiac myofibroblasts. These observations cannot be attributed to methodological variance since, in agreement with the study of Fahling et al. [16], we also observed a significant increase in activation of MMP-2 by hypoxia in HT-1080 cells. Our findings for human cardiac myofibroblasts therefore represent a novel response to hypoxia.
###end p 55
###begin p 56
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 232 239 232 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 453 457 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">[33]</xref>
In vitro studies are usually conducted in an atmosphere of 95% air. This represents an O2 level of 20%; far greater than any cellular exposure in vivo. Our data emphasise the powerful effects of reducing O2 levels to those observed in vivo during clinically important insults such as MI. Clearly, this level of hypoxia has profound effects on protein expression which can be mediated by numerous transcription factors including HIF-1, NFkappaB and CREB [33].
###end p 56
###begin p 57
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">[34]</xref>
###xml 692 699 692 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16 bib32" ref-type="bibr">[16,32]</xref>
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">[35]</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">[17]</xref>
###xml 1317 1321 1305 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">[36]</xref>
###xml 1370 1374 1358 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">[32]</xref>
TIMP-2, in addition to its principal role as the naturally-occurring physiological inhibitor of MMP-2, is also required for its activation, albeit at lower concentrations [34]. In our present study, although TIMP-2 was consistently detected, its concentration in conditioned media of both normoxic and hypoxic myofibroblasts was similar and therefore changes in TIMP-2 levels could not account for our observed changes in MMP-2 activation. It is well established that MT1-MMP is pivotal to MMP-2 activation; however reports are inconsistent with respect to its modulation under hypoxic conditions. That MT1-MMP mRNA was unchanged by hypoxia in our study is in agreement with previous reports [16,32] although both those studies used inherently invasive cell lines and moreover, both reported increased MMP-2 activation in contrast to our observed decrease. However, other studies have reported either increased [35] or decreased [17] MT1-MMP mRNA levels, further emphasising the species and cell-type specific response to hypoxia. Here, although MT1-MMP mRNA levels were not modulated by hypoxia, total levels of protein within the cell and most importantly at the cell membrane were attenuated by approximately 40%. Hypoxia was reported to reduce membrane-associated MT1-MMP in isolated porcine ventricular myocytes [36], but was increased in a breast cancer cell line [32], emphasising a role of MT1-MMP as a key regulator of cellular invasion.
###end p 57
###begin p 58
###xml 982 989 982 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37 bib38 bib39 bib40" ref-type="bibr">[37&#8211;40]</xref>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">[38]</xref>
###xml 1194 1198 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">[39]</xref>
###xml 714 719 <span type="species:ncbi:9606">human</span>
###xml 1065 1070 <span type="species:ncbi:9606">human</span>
In direct contrast to previous reports in other cell types, chronic hypoxia significantly attenuated myofibroblast invasion in the present study. The reduced availability of membrane-associated MT1-MMP would be anticipated to prohibit ternary complex formation and thus lessen MMP-2 activation, accounting for the significant inhibition of invasion. We therefore demonstrated that transfection of myofibroblasts with MMP-2 siRNA reduced total MMP-2 secretion; additionally transfection with MT1-MMP siRNA resulted in both reduced membrane expression of MT1-MMP and reduced MMP-2 activation. Together these observations clearly delineate an essential role for both molecules in the mechanism of MMP-2 activation in human cardiac myofibroblasts. We therefore performed mechanistic and functional studies in parallel and confirmed that cardiac myofibroblast invasion was unequivocally dependent on MT1-MMP. These findings are in agreement with reports in other fibroblastic cell types [37-40]. Our study also indicated that knockdown of MMP-2 inhibited invasion as in human mesenchymal stem cells [38]. Conversely, others have reported that MMP-2 siRNA did not attenuate invasion by HT-1080 cells [39].
###end p 58
###begin p 59
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">[39]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">[40]</xref>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
In contrast to the significant effect on myofibroblast invasion, our data indicated that chemotaxis (migration) can proceed independently of changes in oxygen tension. Despite the lack of effect of hypoxia on myofibroblast migration, we did however observe a consistent attenuation of active MMP-2 in fibroblast-conditioned medium from these assays. Similarly, using MMP-2 siRNA or MT1-MMP siRNA-transfected cells, migration was not different from that of mock-transfected cells. Our results concur with a study reporting that migration of dermal fibroblasts from MT1-MMP null mice was comparable with those of wild-type mice [39]. However, again cell type differences are reported with MT1-MMP knockdown decreasing migration in HT-1080 cells [40].
###end p 59
###begin p 60
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41" ref-type="bibr">[41]</xref>
###xml 490 497 490 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib42 bib43" ref-type="bibr">[42,43]</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
In the present study, membrane expression of active MT1-MMP in human cardiac myofibroblasts was pivotal for hypoxic modulation of both MMP-2 activation and cellular invasion. Hypoxia did not affect MT1-MMP gene expression and hence must modulate its post-transcriptional regulation. Potential targets for hypoxic regulation of MT1-MMP are many, and include activation of the proenzyme by proprotein convertases [41], membrane localisation, shedding, degradation and MT1-MMP phosphorylation [42,43]. The activity of furin, the proprotein convertase responsible for MT1-MMP activation, was increased under hypoxic conditions and therefore could not be accountable for the decreased levels of MT1-MMP (data not shown). Similarly the amount of soluble ("shed") MT1-MMP in myofibroblast-conditioned media was not enhanced by chronic hypoxia (data not shown). Lysosomal inhibition of MT1-MMP degradation with bafilomycin-A1 led to a concentration-dependent increase in MMP-2 activation, as expected. However, this augmentation was observed under both normoxic and hypoxic conditions, thereby ruling out increased lysosomal activity as the mediator of hypoxia-induced decrease in membrane-associated MT1-MMP. Taken together our data suggest that impairment of MT1-MMP protein translation is the most likely target of hypoxia, thereby reducing its availability for ternary complex formation, and consequent inhibition of MMP-2 activation.
###end p 60
###begin p 61
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">[44]</xref>
###xml 479 483 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">[45]</xref>
###xml 711 715 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">[46]</xref>
###xml 955 959 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">[45]</xref>
###xml 1137 1141 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47" ref-type="bibr">[47]</xref>
###xml 1288 1292 1278 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib48" ref-type="bibr">[48]</xref>
###xml 1344 1348 1334 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49" ref-type="bibr">[49]</xref>
###xml 539 545 <span type="species:ncbi:10090">murine</span>
###xml 848 852 <span type="species:ncbi:10116">rats</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1269 1274 <span type="species:ncbi:9940">sheep</span>
###xml 1317 1322 <span type="species:ncbi:10090">mouse</span>
Hypoxia is only one of numerous cues that influence cardiac matrix remodelling through effects on MMPs, and although our current study investigated hypoxia per se, ischaemia-reperfusion injury is another key regulator of MMP activity that modulates its effects through alternative mechanism(s) [44]. Inflammatory mediators released early after MI also play key roles. For example, TNFalpha modulates long-term remodelling and ventricular dysfunction via increased MMP-2 activity [45]. In contrast, TGFbeta may only play a short-term role; murine studies have reported that anti-TGFbeta therapy prior to experimental MI decreased collagen I and MMP-9 mRNA expression after 3 days, but was ineffective by 8 weeks [46]. Activation of MMP-2 post-MI can have positive or negative effects that appear to be species dependent. For example, MMP-2 knockout rats exhibit preserved cardiac function after MI suggesting that excessive MMP-2 activation is deleterious [45]. In contrast, diabetic mice display reduced cardiac expression of both MMP-2 and MT1-MMP and increased fibrosis suggesting that increased MMP-2 activation plays a positive role [47]. Also worthy of note is that the time course of MMP-2 activation post-MI is variable between species; reportedly within 3 h in sheep infarct zone [48], but not evident in the mouse until 4 days post-MI [49].
###end p 61
###begin p 62
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib50" ref-type="bibr">[50]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib51" ref-type="bibr">[51]</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib52" ref-type="bibr">[52]</xref>
###xml 1114 1121 1114 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 624 629 <span type="species:ncbi:9606">human</span>
###xml 859 864 <span type="species:ncbi:9606">human</span>
###xml 1012 1020 <span type="species:ncbi:9606">patients</span>
###xml 1134 1137 <span type="species:ncbi:9606">man</span>
###xml 1197 1202 <span type="species:ncbi:9606">human</span>
In conclusion, impaired cardiac myofibroblast invasion in vivo as a direct result of a period of oxygen deprivation may have deleterious sequelae on the myocardium by delaying early, adaptive remodelling following MI. Taking into account our own and previously published studies, it is clearly evident that species and cell-type variation is a major determinant of cellular responses to distinct stimuli. The multiplicity of reported differences between studies (for review see [50]) underscores the importance of selecting as far as possible, appropriate experimental models. Such considerations are of direct relevance to human disease, and our use of atrial-derived myofibroblasts may have imposed some constraint on the present study. Canine atrial and ventricular cells are claimed to exhibit inherent differences [51], but importantly, the behaviour of human atrial and ventricular cells has been reported to be similar [52]. The study described here, by the use of cardiac myofibroblasts from a series of patients in well established laboratory models of migration and invasion, endeavours to represent the in vivo scenario in man. Understanding the mechanisms of the effects of hypoxia on human cardiac myofibroblast function may ultimately reveal potential novel targets amenable to therapeutic manipulation.
###end p 62
###begin title 63
Sources of funding
###end title 63
###begin p 64
This work was supported in part by the British Heart Foundation (Junior Research Fellowship FS/05/067) awarded to MEM.
###end p 64
###begin title 65
Acknowledgments
###end title 65
###begin p 66
We are grateful to Stacey Galloway and Jean Kaye for cell culture expertise.
###end p 66
###begin title 67
References
###end title 67
###begin article-title 68
Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?
###end article-title 68
###begin article-title 69
Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulation
###end article-title 69
###begin article-title 70
Myocardial fibrosis: functional significance and regulatory factors
###end article-title 70
###begin article-title 71
Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts
###end article-title 71
###begin article-title 72
###xml 99 102 <span type="species:ncbi:10116">rat</span>
DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril
###end article-title 72
###begin article-title 73
###xml 96 99 <span type="species:ncbi:10116">rat</span>
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure
###end article-title 73
###begin article-title 74
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
###end article-title 74
###begin article-title 75
Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis
###end article-title 75
###begin article-title 76
Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases
###end article-title 76
###begin article-title 77
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions
###end article-title 77
###begin article-title 78
Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis
###end article-title 78
###begin article-title 79
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
Blockade of hypoxia-reoxygenation-mediated collagen type I expression and MMP activity by overexpression of TGF-beta1 delivered by AAV in mouse cardiomyocytes
###end article-title 79
###begin article-title 80
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia
###end article-title 80
###begin article-title 81
Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity
###end article-title 81
###begin article-title 82
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers
###end article-title 82
###begin article-title 83
Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia
###end article-title 83
###begin article-title 84
Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation
###end article-title 84
###begin article-title 85
###xml 43 48 <span type="species:ncbi:9606">human</span>
Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation
###end article-title 85
###begin article-title 86
Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism
###end article-title 86
###begin article-title 87
###xml 73 78 <span type="species:ncbi:9606">human</span>
Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism
###end article-title 87
###begin article-title 88
###xml 94 99 <span type="species:ncbi:9606">human</span>
Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function
###end article-title 88
###begin article-title 89
###xml 20 25 <span type="species:ncbi:9606">human</span>
Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA
###end article-title 89
###begin article-title 90
###xml 36 41 <span type="species:ncbi:9606">human</span>
Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin
###end article-title 90
###begin article-title 91
###xml 21 26 <span type="species:ncbi:9606">human</span>
Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration
###end article-title 91
###begin article-title 92
###xml 50 55 <span type="species:ncbi:9606">human</span>
Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms
###end article-title 92
###begin article-title 93
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy
###end article-title 93
###begin article-title 94
Deletion of the PDGFR-beta gene affects key fibroblast functions important for wound healing
###end article-title 94
###begin article-title 95
###xml 71 76 <span type="species:ncbi:9606">human</span>
Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells
###end article-title 95
###begin article-title 96
Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP-2 in cardiac fibroblasts
###end article-title 96
###begin article-title 97
Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases
###end article-title 97
###begin article-title 98
Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form
###end article-title 98
###begin article-title 99
Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation
###end article-title 99
###begin article-title 100
Hypoxia-responsive transcription factors
###end article-title 100
###begin article-title 101
###xml 140 145 <span type="species:ncbi:9606">human</span>
Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line
###end article-title 101
###begin article-title 102
Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells
###end article-title 102
###begin article-title 103
Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity
###end article-title 103
###begin article-title 104
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling
###end article-title 104
###begin article-title 105
###xml 70 75 <span type="species:ncbi:9606">human</span>
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines
###end article-title 105
###begin article-title 106
Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP
###end article-title 106
###begin article-title 107
Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors
###end article-title 107
###begin article-title 108
Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor
###end article-title 108
###begin article-title 109
Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP)
###end article-title 109
###begin article-title 110
Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration
###end article-title 110
###begin article-title 111
Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB
###end article-title 111
###begin article-title 112
Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?
###end article-title 112
###begin article-title 113
Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction
###end article-title 113
###begin article-title 114
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
###end article-title 114
###begin article-title 115
###xml 162 167 <span type="species:ncbi:9940">sheep</span>
Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep
###end article-title 115
###begin article-title 116
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window
###end article-title 116
###begin article-title 117
Cardiac fibroblasts: at the heart of myocardial remodeling
###end article-title 117
###begin article-title 118
Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences
###end article-title 118
###begin article-title 119
###xml 85 90 <span type="species:ncbi:9606">human</span>
Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts
###end article-title 119
###begin p 120
###xml 247 248 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 266 267 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 404 405 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 415 416 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 646 647 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 656 657 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Effect of collagen and hypoxia on MMP-2 activation in cardiac myofibroblasts and HT-1080 cells. (A) Representative zymography of conditioned media collected from myofibroblasts cultured without (-) or with (+) 50 mug/ml collagen in normoxia (20% O2) or hypoxia (1% O2) for 48 h. (B) Densitometric quantification of active MMP-2. Data are expressed relative to cells cultured in collagen and normoxia. P < 0.001 (n = 6). (C) Representative zymogram of HT-1080 conditioned media under the same experimental conditions (note two bands showing cleavage products). (D) Densitometric quantification of combined intermediate and fully active MMP-2 P < 0.01 (n = 5).
###end p 120
###begin p 121
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 519 520 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 806 807 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 816 817 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Effect of hypoxia on total MMP-2, TIMP-2 and MT1-MMP expression. Cardiac myofibroblasts were cultured with collagen under normoxia or hypoxia for 48 h. Conditioned media were analysed by ELISA for (A) total (pro- and active) MMP-2 or (B) total TIMP-2. NS = not significant (n = 5). (C) Cells were cultured with collagen under normoxia or hypoxia for 24 h before extracting RNA and performing real-time RT-PCR. Data shows quantification of MT1-MMP mRNA levels as a percentage of beta-actin levels. NS = not significant (n = 5). (D) Immunofluorescent detection of MT1-MMP localisation (green) following 48 h of collagen-supplemented culture under normoxic or hypoxic conditions. Nuclei stained with DAPI (blue). Scale bar = 50 mum. (E) Membrane expression of MT1-MMP (ELISA) after 48 h normoxia or hypoxia. P < 0.05 (n = 5). (F) Representative immunoblot of whole cell MT1-MMP expression in lysates prepared following 48 h of collagen-supplemented culture in normoxia and hypoxia with beta-actin as loading control.
###end p 121
###begin p 122
###xml 462 463 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 531 532 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 553 554 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 576 577 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effect of lysosomal inhibition on MMP-2 activation. Cells were cultured for 48 h in normoxia and hypoxia with a range of concentrations of the lysosomal inhibitor bafilomycin-A1. (A) Representative zymography of CM collected from myofibroblasts cultured with 50 mug/ml collagen and 0.3-3 nM bafilomycin-A1 in normoxia and hypoxia for 48 h. (B) Densitometric quantification of active MMP-2. Data are expressed relative to cells cultured in vehicle and normoxia. P < 0.05 for the effect of hypoxia in the absence of bafilomycin-A1 (n = 5). ANOVA values: P = 0.0263 (normoxia), P = 0.0001 (hypoxia).
###end p 122
###begin p 123
###xml 436 437 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 446 447 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 918 919 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Effect of hypoxia on cardiac myofibroblast invasion, migration and proliferation. Invasion assays were performed over a 48 h period in normoxia or hypoxia. Membranes were fixed, stained and cell invasion quantified by counting 10 high power (x400) fields per membrane. (A) Representative fields in normoxic and hypoxic culture. Scale bar = 100 mum. (B) Quantification of invaded cells. Data expressed as average cell number per field. P < 0.05 (n = 7). (C) For migration studies, cells were grown to confluence before creating a uniform scratch wound and incubating in collagen and normoxia/hypoxia for a further 48 h. Representative image of wound assay after 48 h, shows cell migration into denuded wound area in normoxia and hypoxia (original magnification x40). (D). Quantification of migrated cells. Data expressed as number of cells migrated to or further than 500 mum per mm wound width. NS = not significant (n = 5). (E). Co-localisation of alpha-SMA (red) and vimentin (green) following 48 h of culture as seen by immunofluorescence microscopy. Nuclei stained with DAPI (blue). Scale bar = 50 mum. (F). 7-day proliferation profile of cells cultured in normoxia (solid line) and hypoxia (hashed line) in 0.5% and 10% FCS.
###end p 123
###begin p 124
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 652 653 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 662 663 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 709 710 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 722 723 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Effect of MMP-2 and MT1-MMP gene silencing on MMP-2 secretion and activation, and myofibroblast function. For MMP quantification, mock-transfected and siRNA-transfected cardiac myofibroblasts were cultured in collagen for 48 h. Functional assays were performed in parallel using mock-transfected and siRNA-transfected cardiac myofibroblasts. (A) Representative zymography of conditioned media collected at 48 h. (B) Densitometric analysis of MMP-2, NS = not significant, P < 0.01 (n = 5). (C) Membrane MT1-MMP expression determined by ELISA. P < 0.01 (n = 5). (D) Densitometric quantification of active MMP-2 relative to mock-transfected cells. P < 0.01 (n = 5). (E) Quantification of invaded cells, P < 0.01, P < 0.001, (n = 6). (F) Quantification of migrated cells. NS = not significant (n = 6).
###end p 124

